0 (0%)		12-27 00:25
Open: High: Volume: 0		Pre. Close: Low: Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	51.54	1-year :	60.2
Resists	First :	44.13	Second :	51.54
Pivot price	43.77
Supports	First :	43.14	Second :	42.54
MAs	MA(5) :	43.98	MA(20) :	43.74
	MA(100) :	43.08	MA(250) :	0
MACD	MACD :	0.1	Signal :	0.1
%K %D	K(14,3) :	94.8	D(3) :	93.6
RSI	RSI(14): 63.8
52-week	High :	44.13	Low :	35.79

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ POCT ] has closed below upper band by 11.0%. Bollinger Bands are 5.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	44.18 - 44.36	44.36 - 44.51
Low:	43.56 - 43.78	43.78 - 43.97
Close:	43.71 - 44.07	44.07 - 44.38

Fri, 26 Dec 2025
HD Medical’s HD Steth Brings Real-Time ECG And Heart Sounds To The Point Of Care - indica News

Fri, 26 Dec 2025
Hematology Diagnostics Market Advances with AI, Automation, and Point-of-Care Innovation - facilitiesmanagement-now.com

Mon, 22 Dec 2025
Point-of-Care Is Just the Beginning: Doceree 360 Report Maps Three Strategic Imperatives for HCP Engagement Across All Digital Touchpoints - PR Newswire

Mon, 15 Dec 2025
Ensuring Diagnostic Stewardship Through Molecular Point-of-Care Testing - Inside Precision Medicine

Thu, 11 Dec 2025
Point-of-care testing, with Daniel Krajcik, D.O., MBA - Medical Economics

Mon, 01 Dec 2025
Point of Care Testing (POCT) Market Size Worth USD 125.33 Bn by 2034 Amid Growing Adoption of Rapid and AI-Enabled Diagnostic Technologies - BioSpace

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange:
Sector:
Industry:
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.